Wednesday, July 8, 2026

biotech · Solid Tumors · Pancreatic Cancer · MREO

MEREO BIOPHARMA GROUP

News and analysis for MEREO BIOPHARMA GROUP on NovaPharmaNews — regulatory, clinical, and market coverage.

4TH FLOOR, ONE, LONDON, USA HQ
4 Employees
Public company Type
MREO · NYSE Ticker
Company details
Status
Public
HQ
4TH FLOOR, ONE, LONDON, USA
Employees
4
Programs
47
Drugs
22
Patents
18
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning MEREO BIOPHARMA GROUP — regulatory, clinical, and market coverage.

News and analysis for MEREO BIOPHARMA GROUP on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning MEREO BIOPHARMA GROUP yet.

Back to company overview →